A Small-Molecule Inhibitor of Mps1 Blocks the Spindle-Checkpoint Response to a Lack of Tension on Mitotic Chromosomes

Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
Current Biology (Impact Factor: 9.57). 07/2005; 15(11):1070-6. DOI: 10.1016/j.cub.2005.05.020
Source: PubMed


The spindle checkpoint prevents chromosome loss by preventing chromosome segregation in cells with improperly attached chromosomes [1, 2 and 3]. The checkpoint senses defects in the attachment of chromosomes to the mitotic spindle [4] and the tension exerted on chromosomes by spindle forces in mitosis [5, 6 and 7]. Because many cancers have defects in chromosome segregation, this checkpoint may be required for survival of tumor cells and may be a target for chemotherapy. We performed a phenotype-based chemical-genetic screen in budding yeast and identified an inhibitor of the spindle checkpoint, called cincreasin. We used a genome-wide collection of yeast gene-deletion strains and traditional genetic and biochemical analysis to show that the target of cincreasin is Mps1, a protein kinase required for checkpoint function [8]. Despite the requirement for Mps1 for sensing both the lack of microtubule attachment and tension at kinetochores, we find concentrations of cincreasin that selectively inhibit the tension-sensitive branch of the spindle checkpoint. At these concentrations, cincreasin causes lethal chromosome missegregation in mutants that display chromosomal instability. Our results demonstrate that Mps1 can be exploited as a target and that inhibiting the tension-sensitive branch of the spindle checkpoint may be a way of selectively killing cancer cells that display chromosomal instability.

Download full-text


Available from: John A Tallarico, Oct 12, 2015
27 Reads
  • Source
    • "MPS1 is thus considered as a promising drug target for cancer cells. Due to central role of this protein kinase in cell division, several inhibitors of MPS1 have been reported [13]–[15]. In C. albicans, orf19.7293 is the MPS1 homolog of S. cerevisiae. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In Saccharomyces cerevisiae MPS1 is one of the major protein kinase that governs the spindle checkpoint pathway. The S. cerevisiae structural homolog of opportunistic pathogen Candida albicans CaMPS1, is indispensable for the cell viability. The essentiality of Mps1 was confirmed by Homozygote Trisome test. To determine its biological function in this pathogen conditional mutant was generated through regulatable MET3 promoter. Examination of heterozygous and conditional (+Met/Cys) mps1 mutants revealed a mitosis specific arrest phenotype, where mutants showed large buds with undivided nuclei. Flowcytometry analysis revealed abnormal ploidy levels in mps1mutant. In presence of anti-microtubule drug Nocodazole, mps1 mutant showed a dramatic loss of viability suggesting a role of Mps1 in Spindle Assembly Checkpoint (SAC) activation. These mutants were also defective in microtubule organization. Moreover, heterozygous mutant showed defective in-vitro yeast to hyphae morphological transition. Growth defect in heterozygous mutant suggest haploinsufficiency of this gene. qRT PCR analysis showed around 3 fold upregulation of MPS1 in presence of serum. This expression of MPS1 is dependent on Efg1and is independent of other hyphal regulators like Ras1 and Tpk2. Furthermore, mps1 mutants were also sensitive to oxidative stress. Heterozygous mps1 mutant did not undergo morphological transition and showed 5-Fold reduction in colony forming units in response to macrophage. Thus, the vital checkpoint kinase, Mps1 besides cell division also has a role in morphogenesis and oxidative stress tolerance, in this pathogenic fungus.
    PLoS ONE 07/2014; 9(7):e101517. DOI:10.1371/journal.pone.0101517 · 3.23 Impact Factor
  • Source
    • "Mps1 phosphorylates p53 at Thr-18, and this phosphorylation is critical for the stabilization of p53 by interfering with MDM2 binding [58]. Mps1-mediated p53 phosphorylation is also required for the activation of p53-dependent postmitotic checkpoint [58]; thus, inhibition of Mps1 kinase activity causes a defective postmitotic checkpoint and chromosome instability [58, 208]. These findings suggest that Mps1-mediated phosphorylation and subsequent stabilization of p53 may play an important role in the activation of p53 after spindle damage as well as the prevention of aneuploidy/polyploidy [58, 208]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitosis is tightly regulated and any errors in this process often lead to aneuploidy, genomic instability, and tumorigenesis. Deregulation of mitotic kinases is significantly associated with improper cell division and aneuploidy. Because of their importance during mitosis and the relevance to cancer, mitotic kinase signaling has been extensively studied over the past few decades and, as a result, several mitotic kinase inhibitors have been developed. Despite promising preclinical results, targeting mitotic kinases for cancer therapy faces numerous challenges, including safety and patient selection issues. Therefore, there is an urgent need to better understand the molecular mechanisms underlying mitotic kinase signaling and its interactive network. Increasing evidence suggests that tumor suppressor p53 functions at the center of the mitotic kinase signaling network. In response to mitotic spindle damage, multiple mitotic kinases phosphorylate p53 to either activate or deactivate p53-mediated signaling. p53 can also regulate the expression and function of mitotic kinases, suggesting the existence of a network of mutual regulation, which can be positive or negative, between mitotic kinases and p53 signaling. Therefore, deciphering this regulatory network will provide knowledge to overcome current limitations of targeting mitotic kinases and further improve the results of targeted therapy.
    07/2012; 2012:195903. DOI:10.1155/2012/195903
  • Source
    • "It is noteworthy that yeast screens often require significantly higher doses (approximately 5–10x) compared with typical mammalian cell culture screens or in vitro assays (see Figure S1 available online) (Blackburn and Avery, 2003; Buurman et al., 2005; Ericson et al., 2008; Kwak et al., 2011). Although our initial yeast screening concentrations are relatively high (maximum 200 mM), this high dose does not sacrifice specificity (Blackburn and Avery, 2003; Botet et al., 2007; Dias et al., 2010; Dorer et al., 2005; Ericson et al., 2008; Giaever et al., 2004; Khozoie et al., 2009; Kwak et al., 2011; Muré n et al., 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Preselection of compounds that are more likely to induce a phenotype can increase the efficiency and reduce the costs for model organism screening. To identify such molecules, we screened ~81,000 compounds in Saccharomyces cerevisiae and identified ~7500 that inhibit cell growth. Screening these growth-inhibitory molecules across a diverse panel of model organisms resulted in an increased phenotypic hit-rate. These data were used to build a model to predict compounds that inhibit yeast growth. Empirical and in silico application of the model enriched the discovery of bioactive compounds in diverse model organisms. To demonstrate the potential of these molecules as lead chemical probes, we used chemogenomic profiling in yeast and identified specific inhibitors of lanosterol synthase and of stearoyl-CoA 9-desaturase. As community resources, the ~7500 growth-inhibitory molecules have been made commercially available and the computational model and filter used are provided.
    Chemistry & biology 10/2011; 18(10):1273-83. DOI:10.1016/j.chembiol.2011.07.018 · 6.65 Impact Factor
Show more

Similar Publications